NYSE:TOL charts & data provided by TradingView

Latest Insights on TOL

Lock it up, lock it in. Want profits on Beyond Meat? Take them now. Beyond Meat Will Bleed; Microsoft’s JEDI Mind Trick October 28, 2019 by Joseph Hargett Great Stuff Beyond Meat: There Will Be Blood Are you a fan of the meatless wonder? Holding some Beyond Meat Inc. (Nasdaq: BYND) in your portfolio, are you? I can’t say I blame you. BYND is up a massive 300% from its initial public offering (IPO) price of $25. Heck, the shares are even up about 51% […]
Don’t go chasing unicorns; please stick to the indexes and the stocks that you’re used to. WeWork was going to have things its way or nothing at all. WeWork’s Lesson in Unicorn Chasing; Tesla Bears Get Crushed October 24, 2019 by Joseph Hargett Great Stuff The Trouble With Chasing Unicorns I think it’s safe to say that I have a unique sense of humor. That’s putting it politely. It’s definitely not one you find very often in the financial realm. However, the saga of WeWork has brought out the inner cynic in more than a few op-ed writers lately. I […]
Solar stock and solar field 1 Solar Stock to Play the Alternative Energy Revolution October 24, 2019 by Anthony Planas American Investor Today, Investment Opportunities, Trending The hype for solar energy has been going on for decades. Today, the sector is coming into its own. Anthony Planas researched the solar energy sector. He gives you a way to play the upcoming solar revolution. (3-minute read)
Star Wars: The Rise of Skywalker just beat Avengers: Endgame in presale tickets. This is going to be a massive win for Disney. Star Wars Tops Endgame, Disney & Verizon Force Netflix Deeper in Debt October 22, 2019 by Joseph Hargett Great Stuff The Rise of Walt Disney Are you ready for the biggest news today? Hint: It’s not the SoftBank takeover of WeWork — anyone paying attention knew this was going to happen. SoftBank couldn’t afford to lose any more face with its big-time investors. That said, a valuation of between $7.5 billion and $8 billion is […]
biotech ETF and test tubes 1 Biotech ETF to Buy and Ride for the Next 6 Months October 22, 2019 by Chad Shoop American Investor Today, Investing, Investment Opportunities October is a volatile month for the stock market. Last year’s fourth quarter still worries many investors. But Chad Shoop follows a seasonal pattern that historically shows the next six months will be profitable. You don’t want to miss the opportunity to make big money. (4-minute read)

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“Thirteen of my positions are up well over 50% in less than a year since joining your service. Two are in the triple digits with several close behind. My personal money manager, who works for one of the largest banks in the country, is envious of my gains. I never dreamed this was possible. My trips to China to teach English to young Chinese students is now much more affordable. Thank you for your dedication and help.”

- Chris K.

"You have done once again!! You are reminding me of the GREAT Joe DiMaggio with your consistent hitting!! You knocked this one out of the park!"

- Keith S.

“Looks like I have finally found the right person to learn and grow from.”

- James

Share This